TransMedics Group (TMDX)
(Real Time Quote from BATS)
$131.45 USD
+1.47 (1.13%)
Updated May 13, 2024 11:06 AM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TMDX 131.45 +1.47(1.13%)
Will TMDX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
Is Trending Stock TransMedics Group, Inc. (TMDX) a Buy Now?
Will TransMedics (TMDX) Gain on Rising Earnings Estimates?
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
TransMedics Group, Inc. (TMDX) Soars to 52-Week High, Time to Cash Out?
Other News for TMDX
What's Driving Tandem Diabetes Care Inc's Surprising 89% Stock Rally?
Insider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)
TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
10 Health Care Stocks Whale Activity In Today's Session
TransMedics Group (TMDX): A Smart Investment or a Value Trap? An In-Depth Exploration